Chief Scientific Officer
Frank is responsible for the science behind new projects related to controlled release solutions. He brings in over 15 years of R&D experience and advanced project execution in the fields of formulation, nano- and micro-technology, as well as controlled release devices. Frank received his B.S. and M.S. from the Technological University of Montpellier, and PhD degree from Nanyang Technological University, Singapore; performed postdoctoral studies a MIT and Harvard Medical School. He holds 6 US and foreign patents licensed to industry and was listed in Nature Biotechnology as Top Translational Junior Faculty in 2013, and presented 100+ abstracts/papers in international journals and conferences.